The nominating institution FMP on the breakthrough:

Christian Hackenberger has pioneered contributions to the development of protein-based therapeutics, based on the chemical modification and cellular delivery of antibodies to target cancer and viral infections. Highlights include the engineering of an inhibitor against human and avian influenza, and safer next-gen antibody drug conjugates, which outperformed a clinically approved drug against Hodgkin lymphoma.

Tags: Med-Tech, COVID-19, Education, Bio-Tech